The potential of fecal microbiota transplantation in systemic sclerosis

Anna-Maria Hoffmann-Vold; Håvard Fretheim; Henriette Didriksen; Øyvind Molberg

doi:10.1080/1744666X.2019.1707665

The potential of fecal microbiota transplantation in systemic sclerosis

Expert Rev Clin Immunol. 2020 Feb;16(2):117-118. doi: 10.1080/1744666X.2019.1707665. Epub 2020 Jan 6.

Authors

Anna-Maria Hoffmann-Vold^{1

2}, Håvard Fretheim^{1

2}, Henriette Didriksen^{1

2}, Øyvind Molberg^{1

2}

Affiliations

¹ Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

PMID: 31858856
DOI: 10.1080/1744666X.2019.1707665

No abstract available

Keywords: Systemic sclerosis; auto-immune disease; fecal microbiota transplantation; gastrointestinal involvement; microbiome; regulatory affairs; treatment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Dysbiosis / immunology
Dysbiosis / therapy*
Fecal Microbiota Transplantation*
Gastrointestinal Microbiome / immunology*
Gene-Environment Interaction
Humans
Scleroderma, Systemic / immunology
Scleroderma, Systemic / therapy*